SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950133-97-003539
Filing Date
1997-10-16
Accepted
1997-10-16 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH TARGET S.A.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 BB BIOTECH AG SC 13D RE: TRANSKARYOTIC THERAPIES SC 13D 36905
  Complete submission text file 0000950133-97-003539.txt   38899
Mailing Address
Business Address 195 ALBANY STREET CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47221 | Film No.: 97696415
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000